Skip to content

Auriculotherapy for stress and anxiety treatment

Auriculotherapy with silicon tablets and placebo for stress, anxiety and improvement of quality of life: Randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8j8v74
Enrollment
Unknown
Registered
2019-08-19
Start date
2017-04-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Interventions

Control group (without intervention): 42 people answered only the questionnaires before and after six weeks. Placebo group: 41 people received 6 sessions, once a week, with pressed cotton without sil
Procedure/surgery
E02.190.204

Sponsors

Instituto Terapia Integrada e Oriental
Lead Sponsor
Instituto Terapia Integrada e Oriental
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Volunteers with a score on the List of Stress Symptoms of 40 to 120 points corresponding to medium and high stress; Age between 18 and 60 years.

Exclusion criteria

Exclusion criteria: Volunteers who carry out treatment with some complementary practice simultaneously to the data collection; who use controlled-use medications, such as anxiolytics, antidepressants and herbal medicines.

Design outcomes

Primary

MeasureTime frame
Expected reduction of 25% of stress levels according to the List of Stress Symptoms after 6 treatment sessions for the group of auriculotherapy with silicon tablets. ;Reduction of less than 25% of stress levels according to the List of Stress Symptoms after 6 treatment sessions for the placebo group.;No reduction expected for the Control Group without intervention according to the List of Symptoms of Stress after 6 weeks.;Reduction of 38% of stress levels according to the Stress Symptoms List after 6 treatment sessions for the auriculotherapy group with silicon tablets.;Reduction of 29% of stress levels according to the List of Stress Symptoms after 6 sessions of treatment for the placebo group. ;Increase of 6% of stress levels for the Control Group without intervention according to the List of Symptoms of Stress after 6 weeks.

Secondary

MeasureTime frame
Expected reduction of 25% of anxiety levels according to the State Trait Anxiety Inventory after 6 treatment sessions for the group of auriculotherapy with silicon tablets ;Reduction of less than 25% of anxiety levels according to the State Trait Anxiety Inventory after 6 treatment sessions for the placebo group. ;No expected reduction for the Control Group without intervention according to the State Trait Anxiety Inventory after 6 weeks.;Reduction of 19% of anxiety levels according to the State Trait Anxiety Inventory, after 6 treatment sessions for the auriculotherapy group with silicon tablets.;Reduction of 15% of anxiety levels according to the State Trait Anxiety Inventory, after 6 sessions of treatment for the placebo group.;Reduction reached of 1% of anxiety levels according to the State Trait Anxiety Inventory, for the Control Group without intervention, after 6 weeks.

Countries

Brazil

Contacts

Public ContactLeonice Fumiko Kurebayashi

Instituto Terapia Integrada e Oriental

fumieibez@gmail.com+5511991126023

Outcome results

None listed

Source: REBEC (via WHO ICTRP)